Building at the Intersection: Ben Lewis on the One Health Studio Model

  • 6.17.2026
  • Drew Beechler

Agriculture and health aren't separate industries. They share supply chains, workforce challenges, and outcomes that touch the same rural communities. Building real companies at this intersection means understanding both sides, not just picking a technology and pointing it at the problem. That's Ben Lewis's daily work as director of Alloy's One Health Studio, and he brought that perspective to a recent conversation on the AgriNovus Agbioscience podcast.

Watch the Episode

What They Covered

Ben and the AgriNovus team went deep on what it takes to build companies at the intersection of plant, human, and animal health, and why the studio model is built for exactly this kind of complexity.

The market challenges in One Health are structural, not just technical.
Animal health, plant science, and human health don't have clean boundaries. The supply chains, the workforce, and the outcomes are all interconnected. And the experts don't always speak the same language. A veterinary cardiologist and a human cardiologist can be looking at the same disease and using different terminology entirely. That fragmentation extends to regulatory pathways, reimbursement structures, and capital. Most investors fit cleanly into biotech or ag tech or animal health. One Health companies often fit all three a little less cleanly. That's the gap Ben is building into.

The studio model exists because these companies can't be built from the outside.
Ben isn't parachuting in with a deck. He's embedded in the work, building alongside founders, learning the problems firsthand. The studio model creates the conditions for that kind of depth: time, relationships, and enough operating capacity to go after multiple ideas in parallel without losing rigor on any of them.

Corporations have the unfair advantage. Startups have the speed.
One Health Studio exists at the intersection of both. The partnerships Alloy builds bring corporate context, market access, and domain expertise that no standalone startup can replicate. The studio brings the operating model and speed that large organizations can't move at internally. The result is companies that are advantaged from day one.

What Ben sees ahead for the One Health opportunity.
Two big themes. First, AI-accelerated drug discovery. What used to take ten PhDs, ten years, and $100 million can now be compressed into hours using frontier models. Ben sees that as a fundamental reset for early-stage science, not an incremental improvement. Second, AI combined with edge sensors. The ability to process data on-device in the field opens entirely new possibilities in agriculture and animal health. One example he teased: near-real-time geospatial soil mapping that can tell a farmer the mineral content and pH levels, inch-by-inch, top to bottom. The kind of precision that skips fifty years of incremental benchtop research. Underlying both is a bigger thesis: the data layer connecting human, animal, and environmental health is still fragmented and incomplete, and Ben sees that gap as one of the most compelling company-building opportunities in the space right now.

About One Health Studio

One Health Studio is Alloy Partners' dedicated venture studio at the convergence of animal, plant, and human health. Ben Lewis leads the studio, working with corporate partners to co-create companies that couldn't exist without the combination of incumbent advantage and startup speed. The studio has already built and validated multiple ventures in parallel. No single founding team could do that alone.

Alloy's approach to running venture studios has evolved. We now operate agentic venture studios, pairing a human operator with 1,000+ specialized AI agents to build, validate, and launch companies at a pace that wasn't possible before. One Health Studio is the proof of concept. One operator. Multiple companies. Months, not years. It's the same playbook Alloy has run across 40+ companies and eight venture studios, now rebuilt for an era where the cost of building has collapsed.

Related Reading

Interested in what an agentic venture studio could do for your organization? Start the conversation.

Elliott-Keynote
High Alpha Innovation CEO Elliott Parker gave a keynote on AI and the case for human ingenuity.
David Senra Podcast
Founders Podcast host David Senra gave a keynote talk on what it takes to build world-changing companies.
Governments and Philanthropies
High Alpha Innovation General Manager Lesa Mitchell moderated a panel on building through partnerships with governments and philanthropies.
Networking
Alloy provided great networking opportunities for attendees, allowing them to share insights and ideas on their own transformation initiatives.
Sustainability Panel
Southern Company Managing Director, New Ventures Robin Lanier spoke on a panel about the energy sector's sustainability efforts.
Healthcare Panel
Microsoft for Startups Worldwide Lead, Health & Life Sciences Sally Ann Frank took part in our panel on healthcare transformation.
Agriculture Panel.
Make Hay CEO and Co-founder Scott Nelson discussed the ongoing transformation in the food and agriculture value chain.

Stay up to date on the latest with Alloy Partners and the future of venture building.